Dexcom (DXCM) Short-term Investments (2010 - 2017)

Dexcom (DXCM) has 8 years of Short-term Investments data on file, last reported at $107.1 million in Q4 2017.

• Short-term Investments for Q4 2017 came in at $107.1 million, up 266.78% year-over-year; the trailing twelve-month figure through Dec 2017 was $107.1 million (up 266.78% YoY), and the FY2017 annual result was $107.1 million, up 266.78% from the prior year.
• Short-term Investments fell to $107.1 million in Q4 2017 per DXCM's latest filing, from $123.7 million in the prior quarter.
• Over five years, Short-term Investments peaked at $123.7 million in Q3 2017 and troughed at $11.4 million in Q4 2013.
• A 5-year average of $35.4 million and a median of $28.0 million in 2015 frame the typical range for Short-term Investments.
• The sharpest annual moves came in 2013 and 2017: Short-term Investments plunged 71.92% in 2013, then soared 317.91% in 2017.
• A 5-year view of Short-term Investments shows it stood at $11.4 million in 2013, then grew by 3.51% to $11.8 million in 2014, then surged by 146.61% to $29.1 million in 2015, then grew by 0.34% to $29.2 million in 2016, then surged by 266.78% to $107.1 million in 2017.
• Business Quant data shows DXCM's Short-term Investments at $107.1 million in Q4 2017, $123.7 million in Q3 2017, and $100.7 million in Q2 2017.